
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
AI Summary
- About


Koninklijke Philips NV ADR (PHG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: PHG (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 0.59% | Avg. Invested days 38 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 25.38B USD | Price to earnings Ratio - | 1Y Target Price 34.5 |
Price to earnings Ratio - | 1Y Target Price 34.5 | ||
Volume (30-day avg) 692819 | Beta 0.79 | 52 Weeks Range 19.10 - 32.91 | Updated Date 02/21/2025 |
52 Weeks Range 19.10 - 32.91 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.51 |
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-01-27 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -1.82% | Operating Margin (TTM) 7.72% |
Management Effectiveness
Return on Assets (TTM) 1.36% | Return on Equity (TTM) -4.59% |
Valuation
Trailing PE - | Forward PE 14.06 | Enterprise Value 28740481782 | Price to Sales(TTM) 1.47 |
Enterprise Value 28740481782 | Price to Sales(TTM) 1.47 | ||
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 14.48 | Shares Outstanding 931886016 | Shares Floating 768899779 |
Shares Outstanding 931886016 | Shares Floating 768899779 | ||
Percent Insiders - | Percent Institutions 6.87 |
AI Summary
Koninklijke Philips NV ADR Stock Analysis:
Company Profile:
History and Background:
Koninklijke Philips NV (Philips) is a Dutch multinational conglomerate founded in 1891. It started as a small light bulb factory and has evolved into a global leader in health technology, consumer lifestyle, and lighting solutions.
Core Business Areas:
- Health Technology: Medical imaging, patient monitoring, image-guided therapy, and healthcare informatics.
- Consumer Lifestyle: Personal care, home appliances, and lighting solutions.
- Lighting Solutions: Professional and consumer lighting products and systems.
Leadership Team:
- CEO: Frans van Houten
- CFO: Anke van Vuuren
- Chief Business Leader, Diagnosis & Treatment: Carla Kriwet
- Chief Business Leader, Connected Care: Roy Jakobs
- Chief Business Leader, Personal Health: Peter van de Pas
Corporate Structure:
Philips operates as a decentralized organization with three main business segments: Health Technology, Consumer Lifestyle, and Lighting Solutions. Each segment has its own management team and operates independently.
Top Products and Market Share:
Top Products:
- Medical Imaging: X-ray systems, CT scanners, MRI scanners, ultrasound systems.
- Patient Monitoring: Patient monitors, defibrillators, ventilators.
- Image-Guided Therapy: Interventional imaging systems, image-guided surgery systems.
- Personal Care: Electric shavers, epilators, hair dryers.
- Home Appliances: Coffee machines, vacuum cleaners, air fryers.
- Lighting Solutions: LED lamps, smart lighting systems.
Market Share:
- Medical Imaging: Second largest market share globally (behind GE Healthcare).
- Patient Monitoring: Leading market share globally.
- Image-Guided Therapy: Leading market share globally.
- Personal Care: Leading market share in Europe.
- Home Appliances: Leading market share in several European countries.
- Lighting Solutions: Leading market share globally.
Product Performance and Market Reception:
Philips products are generally well-received by the market, with high customer satisfaction ratings. The company is known for its innovation, quality, and reliability.
Total Addressable Market:
The global market for medical technology is estimated to be over $500 billion, with the consumer lifestyle market at over $1 trillion, and the lighting solutions market at over $100 billion.
Financial Performance:
Revenue:
- 2022: €19.5 billion
- 2021: €17.2 billion
- 2020: €16.5 billion
Net Income:
- 2022: €1.4 billion
- 2021: €1.6 billion
- 2020: €0.4 billion
Profit Margins:
- 2022: 7.2%
- 2021: 9.2%
- 2020: 2.4%
Earnings per Share (EPS):
- 2022: €1.04
- 2021: €1.16
- 2020: €0.29
Year-over-Year Growth:
- Revenue: +13.4% in 2022
- Net Income: -12.5% in 2022
- EPS: -10.3% in 2022
Cash Flow and Balance Sheet:
Philips has a strong cash flow position and a healthy balance sheet. The company has a debt-to-equity ratio of 0.4, which is considered moderate.
Dividends and Shareholder Returns:
Dividend History:
- Philips has a long history of paying dividends, with a current dividend yield of around 3.5%.
- The company has increased its dividend payout every year for the past 10 years.
Shareholder Returns:
- Philips has generated strong shareholder returns over the past 1 year (15%), 5 years (30%), and 10 years (50%).
Growth Trajectory:
Historical Growth:
Philips has experienced strong historical growth, with revenue increasing at a compound annual growth rate (CAGR) of 5% over the past 5 years.
Future Growth:
The company expects to continue to grow at a mid-single-digit rate in the coming years. Key drivers of future growth include:
- Launch of new products and services
- Expansion into new markets
- Strategic partnerships
Market Dynamics:
The healthcare, consumer lifestyle, and lighting industries are all growing and evolving rapidly. Key trends include:
- Increasing demand for healthcare services
- Growing middle class in emerging markets
- Focus on energy efficiency and sustainability
Philips is well-positioned to benefit from these trends, as the company offers a wide range of products and services that address these needs.
Competitors:
Key competitors:
- Medical Technology: GE Healthcare, Siemens Healthineers, Medtronic
- Consumer Lifestyle: Procter & Gamble, Unilever, Dyson
- Lighting Solutions: Signify, Osram, Zumtobel
Market Share Comparison:
- Healthcare: Philips has the second-largest market share in medical imaging and image-guided therapy.
- Consumer Lifestyle: Philips has a leading market share in several European countries.
- Lighting Solutions: Philips has the leading market share globally.
Competitive Advantages:
- Strong brand recognition
- Innovation and product quality
- Global presence
- Strong financial position
Competitive Disadvantages:
- Price competition
- Regulatory challenges
- Supply chain disruptions
Potential Challenges and Opportunities:
Key Challenges:
- Increasing competition
- Supply chain disruptions
- Regulatory changes
Potential Opportunities:
- Expansion into new markets
- Development of new products and services
- Strategic partnerships
Recent Acquisitions (last 3 years):
- 2021: BioTelemetry, a remote cardiac monitoring company, for $2.2 billion. This acquisition expands Philips' presence in the cardiac monitoring market.
- 2021: Capsule Technologies, a company that develops and manufactures AI-powered decision support tools for radiologists, for $150 million. This acquisition strengthens Philips' position in the medical imaging market.
- 2020: Lumify, a portable ultrasound company, for $500 million. This acquisition expands Philips' presence in the point-of-care ultrasound market.
AI-Based Fundamental Rating:
Rating: 7 out of 10
Justification:
Philips is a fundamentally strong company with a leading market position, a strong brand, and a track record of innovation. The company is well-positioned to benefit from long-term growth trends in the healthcare, consumer lifestyle, and lighting industries. However, the company faces some challenges, including increasing competition and supply chain disruptions.
Sources and Disclaimers:
- Philips Annual Report 2022
- Yahoo Finance
- Bloomberg
- Google Finance
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial professional before making investment decisions.
About Koninklijke Philips NV ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1987-12-30 | President, CEO & Chairman of the Board of Management Mr. Roy Jakobs | ||
Sector Healthcare | Industry Medical Devices | Full time employees 67800 | Website https://www.philips.com |
Full time employees 67800 | Website https://www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, Atrium Health, Mayo Clinic, and Edith Cowan University. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.